The Role of PECAM-1 in Vascular Cell Biologya-Reference-Cited by-同舟云学术

The Role of PECAM-1 in Vascular Cell Biologya

Published:1994-04 Issue:1 Volume:714 Page:165-174
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

NEWMAN PETER J.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1994.tb12041.x/fullpdf

Reference19 articles.

1. Molecular cloning of a 130 kD membrane glycoprotein expressed on human platelets, umbilical vein endothelial cells, and human erythroleukemia (HEL) cells (Abstract);Newman;J. Cell Biol,1987

2. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily;Newman;Science,1990

3. A novel leukocyte differentiation antigen: Two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts;Ohto;Blood,1985

4. Biochemistry and expression of myelomonocytic antigens;Goyert;J. Immunol,1986

5. EndoCAM: A novel endothelial cell-cell adhesion molecule;Albelda;J. Cell Biol,1990

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats;European Journal of Pharmacology;2024-02

2. Single-cell RNA sequencing analysis identifies one subpopulation of endothelial cells that proliferates and another that undergoes the endothelial-mesenchymal transition in regenerating pig hearts;Frontiers in Bioengineering and Biotechnology;2024-01-15

3. Enhancing the Treatment of Uncontrolled Inflammation through the Targeted Delivery of TPCA-1-Loaded Nanoparticles;Pharmaceutics;2023-10-09

4. CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation;eLife;2023-08-07

5. Dual-Targeting Delivery of TPCA-1-Loaded Nanoparticles Improves the Treatment of Uncontrolled Inflammation;2023